
About us
The Detection & Imaging group builds on ANSTO’s 70-year history of scientific achievements and contributions in meeting the nuclear needs of industry, globally.
Showing 141 - 160 of 509 results
The Detection & Imaging group builds on ANSTO’s 70-year history of scientific achievements and contributions in meeting the nuclear needs of industry, globally.
In partnership with the Australian Museum as part of National Science Week explore the 2020 hackathon theme of Deep Blue: Innovation for the future of our oceans
Collaborators used X-ray imaging to understand the fine detail of how a damaging fungal pathogen reduces leaf function and grain yield of wheat crops.
Evidence for existence of a highly exotic and elusive state of matter, known as a magnetic ‘spin nematic’ phase in a natural mineral called linarite.
Unique opportunity to contribute to the long term conservation of Australia’s most iconic landmark: The Sydney Harbour Bridge.
ANSTO contributes to new international project to improve how the world assesses the economic viability of Small Modular Reactors
ANSTO and the Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) have been recognised for their valuable contributions to the search and recovery efforts for a missing 8mm-long radioactive capsule in the Western Australian outback.
ANSTO is proud to host the Shorebirds Competition for the fourth year. This unique environmental poster competition is free to enter and offers over $4000 in prizes (insert link to prizes button) for students and schools!
Developed by ANSTO’s predecessor the Australian Atomic Energy Commission (known as the AAEC) in the late 1960s, the Technetium-99m Generator revolutionised nuclear medicine imaging in Australia by enabling imaging procedures to be performed not only in major capital cities but throughout regional and rural Australia.
Detailed data on ANSTO electricity use and CO2 emissions for FY2022 - FY2023
ANSTO’s nuclear medicine processing and distribution facility assembles, loads, tests and distributes a range of nuclear medicine products, including Mo-99. The Mo-99 is dispensed into an ANSTO radiopharmaceutical Gentech® Generator where it decays to Tc-99m.
With more than 50 years of experience in monitoring natural and anthropogenic radionuclides in the environment, ANSTO can provide the crucial data and insights you need to assist with the planning and risk management associated with oil and gas decommissioning.
With over 70 years of nuclear expertise, ANSTO offers expert education and training programs
With a well-established portfolio of nuclear research and the operation of Australia's only nuclear reactor OPAL, ANSTO scientists conduct both fundamental and applied research on fuel for current, advanced, and future nuclear technology systems.
The High Performance Macromolecular Crystallography beamline will enable the study of very small (sub-5 micrometre) or weakly diffracting crystals, providing a state-of-the-art high-throughput facility for researchers. MX3 will be able to study the structures of large proteins and protein complexes for virology, drug design and industrial applications via goniometer mounted crystals, in-tray screening, or via serial crystallography methods.
The BRIGHT Project will expand the beamline infrastructure of the Australian Synchrotron to increase both its capacity and capabilities.
ANSTO recognised the contribution of individuals and teams to nuclear science and technology at the 2023 ANSTO Awards Ceremony held on 25 July.
First Asia Oceania Forum held at the Australian Synchrotron